
For your pediatric patients 6 to 17 years of age
with functional constipation
RELIEF IS THE GOAL
LINZESS is approved for the treatment of functional constipation in pediatric patients 6 to 17 years of age.1
Please see Important Safety Information, including Boxed Warning, below.
Please see link for full Prescribing Information
above for additional information.
Not an actual patient.
Reference: 1. LINZESS. Prescribing Information. AbbVie Inc.; 2023.
US-LIN-230092